← All trends
Confidence: StrongAs of 2026-07-10
global · market pattern
PCOS market: 2.1M searches a month
About 2.1M people a month search PCOS across 30 tracked markets. The products this group turns to are led by Glp 1, Tirzepatide, Semaglutide.
What the PCOS economy actually looks like, sized by real search demand and the products people turn to.
What it isthe hormonal condition affecting roughly 1 in 10 women of reproductive age
Working hypothesisAI-suggested
PCOS searchers increasingly land on metabolic tools, berberine and GLP-1 drugs, treating it as an insulin-resistance problem rather than only a fertility one.
The evidence
- condition demand
- 2.1M searches a month for PCOS itself, summed across 30 tracked markets (2026-06) [MEASURED]
- top linked demand
- Glp 1: 3.9M searches a month [MEASURED]
- map
- 7 products mapped to PCOS in the demand-driver map [MEASURED edges, INFERRED that this population searches and buys them]
- note
- Headline is search demand for the condition term itself, a clean measured number. Linked products are ranked by their own global demand; they overlap across conditions (a GLP-1 search is not only a PCOS search), so they are shown as a leaderboard, not summed into a single market size. Money and sales are not measured.
The full ranking
6 tracked · pcos demand-driver map.
- 1Glp 13.9M/mo, +10% 6mo
- 2Tirzepatide3.2M/mo, +28% 6mo
- 3Semaglutide2.1M/mo
- 4Berberine2.1M/mo, +31% 6mo
- 5Continuous Glucose Monitor1M/mo, +6% 6mo
- 6Medical Weight Loss973K/mo, +29% 6mo